These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30587449)
1. Novel, potent, selective, and brain penetrant phosphodiesterase 10A inhibitors. Geneste H; Drescher K; Jakob C; Laplanche L; Ochse M; Torrent M Bioorg Med Chem Lett; 2019 Feb; 29(3):406-412. PubMed ID: 30587449 [TBL] [Abstract][Full Text] [Related]
2. Discovery of [¹¹C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors. Cox CD; Hostetler ED; Flores BA; Evelhoch JL; Fan H; Gantert L; Holahan M; Eng W; Joshi A; McGaughey G; Meng X; Purcell M; Raheem IT; Riffel K; Yan Y; Renger JJ; Smith SM; Coleman PJ Bioorg Med Chem Lett; 2015 Nov; 25(21):4893-4898. PubMed ID: 26077491 [TBL] [Abstract][Full Text] [Related]
3. Discovery of imidazo[1,5-a]pyrido[3,2-e]pyrazines as a new class of phosphodiesterase 10A inhibitiors. Höfgen N; Stange H; Schindler R; Lankau HJ; Grunwald C; Langen B; Egerland U; Tremmel P; Pangalos MN; Marquis KL; Hage T; Harrison BL; Malamas MS; Brandon NJ; Kronbach T J Med Chem; 2010 Jun; 53(11):4399-411. PubMed ID: 20450197 [TBL] [Abstract][Full Text] [Related]
4. Benzothiophene derivatives as phosphodiesterase 10A (PDE10A) inhibitors: Hit-to-lead studies. Kawamoto Y; Tomino M; Hiramatsu K; Oyama Y; Hayashi Y Bioorg Med Chem Lett; 2019 Jun; 29(11):1419-1422. PubMed ID: 30952590 [TBL] [Abstract][Full Text] [Related]
5. Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A). Hu E; Chen N; Bourbeau MP; Harrington PE; Biswas K; Kunz RK; Andrews KL; Chmait S; Zhao X; Davis C; Ma J; Shi J; Lester-Zeiner D; Danao J; Able J; Cueva M; Talreja S; Kornecook T; Chen H; Porter A; Hungate R; Treanor J; Allen JR J Med Chem; 2014 Aug; 57(15):6632-41. PubMed ID: 25062128 [TBL] [Abstract][Full Text] [Related]
6. Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A). Hu E; Kunz RK; Chen N; Rumfelt S; Siegmund A; Andrews K; Chmait S; Zhao S; Davis C; Chen H; Lester-Zeiner D; Ma J; Biorn C; Shi J; Porter A; Treanor J; Allen JR J Med Chem; 2013 Nov; 56(21):8781-92. PubMed ID: 24102193 [TBL] [Abstract][Full Text] [Related]
7. Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability. Chino A; Masuda N; Amano Y; Honbou K; Mihara T; Yamazaki M; Tomishima M Bioorg Med Chem; 2014 Jul; 22(13):3515-26. PubMed ID: 24837154 [TBL] [Abstract][Full Text] [Related]
8. Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Raheem IT; Schreier JD; Fuerst J; Gantert L; Hostetler ED; Huszar S; Joshi A; Kandebo M; Kim SH; Li J; Ma B; McGaughey G; Sharma S; Shipe WD; Uslaner J; Vandeveer GH; Yan Y; Renger JJ; Smith SM; Coleman PJ; Cox CD Bioorg Med Chem Lett; 2016 Jan; 26(1):126-32. PubMed ID: 26602277 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility. Rzasa RM; Frohn MJ; Andrews KL; Chmait S; Chen N; Clarine JG; Davis C; Eastwood HA; Horne DB; Hu E; Jones AD; Kaller MR; Kunz RK; Miller S; Monenschein H; Nguyen T; Pickrell AJ; Porter A; Reichelt A; Zhao X; Treanor JJS; Allen JR Bioorg Med Chem; 2014 Dec; 22(23):6570-6585. PubMed ID: 25456383 [TBL] [Abstract][Full Text] [Related]
10. Use of structure based design to increase selectivity of pyridyl-cinnoline phosphodiesterase 10A (PDE10A) inhibitors against phosphodiesterase 3 (PDE3). Hu E; Kunz RK; Rumfelt S; Andrews KL; Li C; Hitchcock SA; Lindstrom M; Treanor J Bioorg Med Chem Lett; 2012 Nov; 22(22):6938-42. PubMed ID: 23044369 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193. Hostetler ED; Fan H; Joshi AD; Zeng Z; Eng W; Gantert L; Holahan M; Meng X; Miller P; O'Malley S; Purcell M; Riffel K; Salinas C; Williams M; Ma B; Buist N; Smith SM; Coleman PJ; Cox CD; Flores BA; Raheem IT; Cook JJ; Evelhoch JL Mol Imaging Biol; 2016 Aug; 18(4):579-87. PubMed ID: 26596571 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibition. Hamaguchi W; Masuda N; Isomura M; Miyamoto S; Kikuchi S; Amano Y; Honbou K; Mihara T; Watanabe T Bioorg Med Chem; 2013 Dec; 21(24):7612-23. PubMed ID: 24238902 [TBL] [Abstract][Full Text] [Related]
13. Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors. Kehler J; Ritzen A; Langgård M; Petersen SL; Farah MM; Bundgaard C; Christoffersen CT; Nielsen J; Kilburn JP Bioorg Med Chem Lett; 2011 Jun; 21(12):3738-42. PubMed ID: 21602043 [TBL] [Abstract][Full Text] [Related]
14. Discovery of selective biaryl ethers as PDE10A inhibitors: improvement in potency and mitigation of Pgp-mediated efflux. Rzasa RM; Hu E; Rumfelt S; Chen N; Andrews KL; Chmait S; Falsey JR; Zhong W; Jones AD; Porter A; Louie SW; Zhao X; Treanor JJ; Allen JR Bioorg Med Chem Lett; 2012 Dec; 22(24):7371-5. PubMed ID: 23149228 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR study of novel tricyclic pyrazoles as potent phosphodiesterase 10A inhibitors. Dore A; Asproni B; Scampuddu A; Pinna GA; Christoffersen CT; Langgård M; Kehler J Eur J Med Chem; 2014 Sep; 84():181-93. PubMed ID: 25016376 [TBL] [Abstract][Full Text] [Related]
16. AMG 580: a novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer. Chen H; Lester-Zeiner D; Shi J; Miller S; Glaus C; Hu E; Chen N; Able J; Biorn C; Wong J; Ma J; Michelsen K; Hill Della Puppa G; Kazules T; Dou HH; Talreja S; Zhao X; Chen A; Rumfelt S; Kunz RK; Ye H; Thiel OR; Williamson T; Davis C; Porter A; Immke D; Allen JR; Treanor J J Pharmacol Exp Ther; 2015 Feb; 352(2):327-37. PubMed ID: 25502803 [TBL] [Abstract][Full Text] [Related]
17. Highly potent, selective, and orally active phosphodiesterase 10A inhibitors. Malamas MS; Ni Y; Erdei J; Stange H; Schindler R; Lankau HJ; Grunwald C; Fan KY; Parris K; Langen B; Egerland U; Hage T; Marquis KL; Grauer S; Brennan J; Navarra R; Graf R; Harrison BL; Robichaud A; Kronbach T; Pangalos MN; Hoefgen N; Brandon NJ J Med Chem; 2011 Nov; 54(21):7621-38. PubMed ID: 21988093 [TBL] [Abstract][Full Text] [Related]
18. Fragment-assisted hit investigation involving integrated HTS and fragment screening: Application to the identification of phosphodiesterase 10A (PDE10A) inhibitors. Varnes JG; Geschwindner S; Holmquist CR; Forst J; Wang X; Dekker N; Scott CW; Tian G; Wood MW; Albert JS Bioorg Med Chem Lett; 2016 Jan; 26(1):197-202. PubMed ID: 26597534 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro characterization of cinnoline and benzimidazole analogues as phosphodiesterase 10A inhibitors. Yang H; Murigi FN; Wang Z; Li J; Jin H; Tu Z Bioorg Med Chem Lett; 2015 Feb; 25(4):919-24. PubMed ID: 25592707 [TBL] [Abstract][Full Text] [Related]
20. Novel triazines as potent and selective phosphodiesterase 10A inhibitors. Malamas MS; Stange H; Schindler R; Lankau HJ; Grunwald C; Langen B; Egerland U; Hage T; Ni Y; Erdei J; Fan KY; Parris K; Marquis KL; Grauer S; Brennan J; Navarra R; Graf R; Harrison BL; Robichaud A; Kronbach T; Pangalos MN; Brandon NJ; Hoefgen N Bioorg Med Chem Lett; 2012 Sep; 22(18):5876-84. PubMed ID: 22902656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]